In particular, the reduction in muscle weight of AAV9-MITOK injected muscles was more than 50% both 4 and 8 weeks after the infection (Fig. 5A-B, S3B), which was due to great decrease of the mean fibre area compared to controls (Fig. 5C, S3C). The gene discussed is CCDC51; the disease is infection.